Amgen Inc (AMGN): EPS (Diluted)
$14.23
Year ended 2025-12-31
+5.5%
3-year compound annual growth
+2.9%
5-year compound annual growth
+4.6%
10-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.23 | +88.2% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $7.56 | -39.5% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $12.49 | +3.1% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $12.11 | +17.8% | 2025-02-14, From 2022-01-01 |
| 2021-12-31 | $10.28 | -16.5% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $12.31 | -4.4% | 2023-02-09, From 2020-01-01 |
| 2019-12-31 | $12.88 | +2.1% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $12.62 | +369.1% | 2021-02-09, From 2018-01-01 |
| 2017-12-31 | $2.69 | -73.7% | 2020-02-12, From 2017-01-01 |
| 2016-12-31 | $10.24 | +13.0% | 2019-02-13, From 2016-01-01 |
| 2015-12-31 | $9.06 | +35.2% | 2018-02-13, From 2015-01-01 |
| 2014-12-31 | $6.70 | +0.9% | 2017-02-14, From 2014-01-01 |
| 2013-12-31 | $6.64 | +20.3% | 2016-02-16, From 2013-01-01 |
| 2012-12-31 | $5.52 | +36.6% | 2015-02-19, From 2012-01-01 |
| 2011-12-31 | $4.04 | -15.7% | 2014-02-24, From 2011-01-01 |
| 2010-12-31 | $4.79 | +6.2% | 2013-02-27, From 2010-01-01 |
| 2009-12-31 | $4.51 | +19.6% | 2012-02-29, From 2009-01-01 |
| 2008-12-31 | $3.77 | +37.6% | 2011-02-25, From 2008-01-01 |
| 2007-12-31 | $2.74 | n/a | 2010-03-01, From 2007-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Amgen Inc (AMGN) | 2025-12-31 | $14.23 | +88.2% |
| Gilead Sciences, Inc. (GILD) | 2025-12-31 | $6.78 | n/m |
| Biogen Inc. (BIIB) | 2025-12-31 | $8.79 | -21.4% |
| Neurocrine Biosciences Inc (NBIX) | 2025-12-31 | $4.67 | +41.9% |
| Exelixis, Inc. (EXEL) | 2026-01-02 | $2.78 | +58.0% |
| Qiagen N.V. (QGEN) | 2025-12-31 | $1.94 | +424.3% |
| Moderna, Inc. (MRNA) | 2025-12-31 | -$7.26 | n/m |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $2.56 | -25.4% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $1.16 | +152.2% |
Compare AMGN, GILD, BIIB, NBIX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗